Encinitas, California--(Newsfile Corp. - April 14, 2026) - Kiora Pharmaceuticals (KPRX) (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of KIO-301 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results